De Novo Pharmaceuticals Overview
- Year Founded
-
1999
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Out of Business
De Novo Pharmaceuticals General Information
Description
Provider of a drug discovery platform designed to provide computerized drug design systems. The company's drug discovery platform focuses on small molecule therapeutics and a suite of software tools for the analysis of structural information on a protein target, providing drug developers a greater scope to optimize molecules.
Contact Information
Website
www.denovopharma.comCorporate Office
- Compass House, Vision Park
- Histon
- Cambridge CB4 9ZR
- England, United Kingdom
Corporate Office
- Compass House, Vision Park
- Histon
- Cambridge CB4 9ZR
- England, United Kingdom
De Novo Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 01-Aug-2015 | Completed | Out of Business | |||
| 4. Secondary Transaction - Private | 01-Mar-2006 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 20-May-2005 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 22-Jul-2001 | $23.9M | $26.8M | Completed | Startup | |
| 1. Early Stage VC | 01-Apr-2001 | $2.88M | $2.88M | Completed | Startup |
De Novo Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
De Novo Pharmaceuticals Patents
De Novo Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-0410114-D0 | Compounds and their use | Inactive | 06-May-2004 | ||
| GB-0328268-D0 | Compounds and their use | Inactive | 05-Dec-2003 | ||
| GB-0321301-D0 | Compounds and their use | Inactive | 11-Sep-2003 | ||
| GB-0300805-D0 | Compounds and their use | Inactive | 14-Jan-2003 | ||
| GB-2397301-A | Substituted 1,3,5-triazine derivatives | Inactive | 14-Jan-2003 | C07D403/04 |
De Novo Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
De Novo Pharmaceuticals FAQs
-
When was De Novo Pharmaceuticals founded?
De Novo Pharmaceuticals was founded in 1999.
-
Where is De Novo Pharmaceuticals headquartered?
De Novo Pharmaceuticals is headquartered in Cambridge, United Kingdom.
-
What is the size of De Novo Pharmaceuticals?
De Novo Pharmaceuticals has 11 total employees.
-
What industry is De Novo Pharmaceuticals in?
De Novo Pharmaceuticals’s primary industry is Drug Discovery.
-
Is De Novo Pharmaceuticals a private or public company?
De Novo Pharmaceuticals is a Private company.
-
What is De Novo Pharmaceuticals’s current revenue?
The current revenue for De Novo Pharmaceuticals is .
-
How much funding has De Novo Pharmaceuticals raised over time?
De Novo Pharmaceuticals has raised $29.6M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
